Artificial Intelligence

Online lender Loanz pivots from a tough US market to focus on Canada, deploying AI to serve a growing number of underserved Canadian borrowers.

An innovative RNA-editing therapy for hepatocellular carcinoma has received a major FDA designation, potentially accelerating its path to patients.

A new fund, NICO, challenges ESG norms by investing in tobacco giants, aiming to force a shift to safer products. Can engagement succeed where exclusion has failed?

A three-month FDA delay for a new LEQEMBI injection highlights the high-stakes race for a convenient Alzheimer's therapy and its complex safety hurdles.

A KIST-led delegation of Korean quantum startups partners with IBM, signaling a major push to commercialize deep tech on the global stage.

A Swedish startup is launching a 'participation-first' video app in Brazil, betting that users are tired of passive scrolling. Can it succeed?

The Federation of Thai Industries' support for IME 2026 creates a vital platform for China-Thailand tech exchange, accelerating the region's digital shift.

Avnet's new integration facility in Singapore is more than a building; it's a strategic move in the global shift to diversify tech supply chains beyond China.

Record overseas buyer attendance at the 139th Canton Fair highlights a strategic pivot to high-tech, innovative manufacturing, reshaping global trade.

The healthcare intelligence giant boosts its buyback program, a move analysts see as a bold bet on its own value and a strategic play in a shifting industry.

The service commerce platform saw net income jump over 700% despite a drop in adjusted EBITDA, signaling a massive strategic bet on its AI-driven future.

As complex new global AI and data laws take effect, Canadian businesses are scrambling for guidance, fueling a boom in specialized advisory services.

The cloud company's results show modest growth, but a strategic pivot to shed a recent acquisition and focus on its 'Dash' AI tool is paying off.

With a strong balance sheet and promising data, Enliven Therapeutics is pushing its lead leukemia drug, ELVN-001, into a pivotal late-stage trial.

Semiconductor giant KLA announces a massive stock split and a 21% dividend hike, rewarding shareholders and making its stock more accessible to all.

Artivion posts strong Q1 results and acquires Endospan for its FDA-approved NEXUS system, yet lowers its full-year guidance. What's behind the mixed message?

Job applications have tripled, but your chance of an interview is down 50%. New data reveals how AI is creating a tougher, more selective hiring market.

Carrington acquires Valon Mortgage and adopts its AI platform, a landmark deal set to redefine the complex world of government mortgage servicing.

New data shows most college students are 'Blank Slates' to AI hiring systems. Are universities and traditional career prep failing an entire generation?

The Better Future Forum will convene 200 experts in Singapore to reshape education for a world disrupted by AI, conflict, and growing learning gaps.